Results 31 to 40 of about 62,115,225 (162)

Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in klatskin tumor patients [PDF]

, 2015
Curative treatment of intrahepatic cholangiocarcinoma (ICC) and hilar cholangiocarcinoma (Klatskin tumors) is limited to surgical resection or orthotopic liver transplantation.
Ulrike Stein, Pratschke, J., Daniel Seehofer, Schlag, P., Stein, U., Lederer, A., Dietel, M., Andri Lederer, Herrmann, P., Johann Pratschke, Peter Schlag, Pia Herrmann, Manfred Dietel, Seehofer, D.   +13 more
core   +1 more source

Antegrade Endobiliary Forceps Biopsy Improves Diagnosis of Klatskin Tumor Compared to Brush Biopsy [PDF]

, 2022
Aim. To evaluate the safety and accuracy of percutaneous transhepatic biliary biopsy in patients with suspected Klatskin tumor.Materials and methods. Between 2013–2020, percutaneous transhepatic biliary drainage (PTBD) was performed in 52 patients with ...
A. I. Urbansky, G. M. Yakshieva, A. A. Polikarpov, A. V. Moiseenko, P. G. Tarazov, M. V. Yutkin, D. A. Granov, A. V. Kozlov   +7 more
core   +1 more source

Paciente con colangiocarcinoma hiliar (tumor de Klatskin) : Reporte de caso.

, 2017
El carcinoma del conducto biliar o colangiocarcionoma es un carcinoma dependiente de los conductos biliares, dentro de estos se encuentra el colangiocarcinoma dependiente de la confluencia hiliar (tumor de klatskin), el CC representa menos del 2% de ...
Morales Echeverry, Julián, Osorio Navarro, Nerley   +1 more
core   +1 more source

Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 5, May 2025.
ABSTRACT Background The absence of validated methods to identify cholangiocarcinoma in real‐world data has prevented the conduct of pharmacoepidemiologic studies to evaluate determinants of this malignancy and examine the effectiveness of cholangiocarcinoma treatments.
Nicole D. Ferrante, Rebecca A. Hubbard, Kelley Weinfurtner, Anya I. Mezina, Craig W. Newcomb, Emma E. Furth, Debika Bhattacharya, Basile Njei, Tamar H. Taddei, Amit Singal, Maarouf A. Hoteit, Lesley S. Park, David Kaplan, Vincent Lo Re III   +13 more
wiley   +1 more source

Chemoradiation of locally advanced biliary cancer: A PRISMA‐compliant systematic review

Cancer Medicine, Volume 13, Issue 23, December 2024.
This is a systematic review of the current evidence on “modern” chemoradiation for primary or recurrent unresectable biliary tract cancers. We have critically compared chemoradiation outcomes with those of other treatment options, seeking to determine whether specific chemoradiation modalities provide distinct advantages in terms of treatment efficacy ...
Silvia Bisello, Claudio Malizia, Filippo Mammini, Erika Galietta, Federica Medici, Gian Carlo Mattiucci, Francesco Cellini, Andrea Palloni, Luca Tagliaferri, Gabriella Macchia, Francesco Deodato, Savino Cilla, Giovanni Brandi, Alessandra Arcelli, Alessio G. Morganti   +14 more
wiley   +1 more source

Prevalence and Significance of AGR2 Expression in Human Cancer

Cancer Medicine, Volume 13, Issue 21, November 2024.
ABSTRACT Backround Anterior gradient 2 (AGR2) is a resident endoplasmic reticulum (ER) protein with a vital role in embryonal development, mucus maturation, tissue regeneration, and wound healing. Methods To determine the prevalence and clinical significance of AGR2 expression in cancer, a tissue microarray containing 14,966 tumors from 134 different ...
Nina Schraps, Jacob Constantin Port, Anne Menz, Florian Viehweger, Seyma Büyücek, David Dum, Ria Schlichter, Andrea Hinsch, Christoph Fraune, Christian Bernreuther, Martina Kluth, Claudia Hube‐Magg, Katharina Möller, Viktor Reiswich, Andreas M. Luebke, Patrick Lebok, Sören Weidemann, Guido Sauter, Maximilian Lennartz, Frank Jacobsen, Till S. Clauditz, Andreas H. Marx, Ronald Simon, Stefan Steurer, Baris Mercanoglu, Nathaniel Melling, Thilo Hackert, Eike Burandt, Natalia Gorbokon, Sarah Minner, Till Krech, Florian Lutz   +31 more
wiley   +1 more source

Septin 9 expression regulates ‘don't eat me’ signals and identifies an immune–epithelial class of intrahepatic cholangiocarcinoma

Molecular Oncology, Volume 18, Issue 10, Page 2369-2392, October 2024.
Septin 9 is identified as a regulator of EMT and the host immune response. Intrahepatic cholangiocarcinoma (iCCA) was categorized into two groups: (1) ‘immune–epithelial’, with high expression of septin 9 and ‘don't eat me’ signal genes regulated by IFNγ/STAT1; and (2) ‘mesenchymal–ECM’, with high expression of vimentin, MMP7 and TIMP1.
Ting ting Cai, Christophe Desterke, Juan Peng, Jean Agnetti, Peixuan Song, Dalila Ouazib, Alexandre Dos Santos, Catherine Guettier, Didier Samuel, Ama Gassama‐Diagne   +9 more
wiley   +1 more source

Tumor of Klatskin

Acta Médica del Centro, 2017
Se trata de una paciente femenina de 61 años, con antecedentes patológicos personales de hipertensión arterial y hepatitis viral. Tres días previos al ingreso se le practicó una colangiografía retrógrada por vía endoscópica para la extracción de litiasis
Arletis Ferrer Pérez, Mayelín Casas Padrón, Leonardo Ortiz Díaz, Vivian Díaz de Villegas Reguera, Dianelí Lorely Reyes Hernández, Raunel Batista Hernández, Laide Pino Chávez, Javier Alejandro Comas García   +7 more
doaj  

Efficacy and safety of endoscopic ultrasonography (EUS) hepaticogastrostomy (HGS) versus choledochoduodenostomy (CDS) in ERCP‐failed malignant biliary obstruction: A systematic review and META‐analysis

JGH Open, Volume 8, Issue 10, October 2024.
Abstract Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard in managing malignant biliary obstruction. The success of ERCP has limitations, whereas surgical biliary bypass and percutaneous transhepatic approaches, as alternative modalities, come with significant costs, longer durations, and higher levels of mortality and ...
Chrisandi Y Rizqiansyah, Putu I D Awatara, Nasim Amar, Cosmas R A Lesmana, Syifa Mustika   +4 more
wiley   +1 more source

Tumor de Klatskin. Presentación de un paciente [PDF]

, 2007
Klatskin's tumor usually presents as a diffuse nodular lesion, being refered to as colangiocarcinoma. It originates at the confluence of both hepatic ducts. This fact imposes the need of peering at hepatic ducts proximally in colangiography.
López Soler, Julio C., de Armas Prado, Jesús Isaac, Ibáñez Bravo, Luis Alberto   +2 more
core